A Search Service for Abbreviation / Long Form

■検索結果 - 略語 : RRMM

検索条件

検索語：RRMM

検索方法：完全一致

主な研究分野:

結果

略語: RRMM

出現頻度: 908

対応する展開形の数: 16

No.

展開形

主な研究分野

共起略語

PubMed/MEDLINE情報 (発表年, 題目)

relapsed/refractory multiple myeloma

(440回)

Neoplasms

新生物, 腫瘍

(151回)

PFS(133回)

OS(91回)

ORR(89回)

2011How to treat patients with relapsed/refractory multiple myeloma: evidence-based information and opinions.

refractory multiple myeloma

(284回)

Neoplasms

新生物, 腫瘍

(112回)

PFS(63回)

OS(56回)

ORR(50回)

2011Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study.

relapsed/refractory MM

(91回)

Neoplasms

新生物, 腫瘍

(35回)

MM(86回)

PFS(22回)

NDMM(17回)

2011Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma.

refractory MM

(42回)

Hematology

血液学

(14回)

MM(40回)

BCMA(10回)

PFS(8回)

2012Safety and efficacy of lenalidomide in relapsed or refractory multiple myeloma.

refractory/relapsed multiple myeloma

(19回)

Neoplasms

新生物, 腫瘍

(8回)

OS(5回)

ORR(4回)

PFS(4回)

2014Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma.

refractory myeloma

(9回)

Hematology

血液学

(3回)

MM(5回)

ORR(2回)

AKI(1回)

2017Combination therapy with monoclonal antibodies for treatment of newly diagnosed multiple myeloma.

refractory/relapsed MM

(6回)

Neoplasms

新生物, 腫瘍

(3回)

MM(6回)

NDMM(4回)

PFS(2回)

2016Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy.

relapsed/refractory myeloma

(6回)

Hematology

血液学

(3回)

MM(2回)

ORR(2回)

ASCT(1回)

2021An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myeloma.

real-time respiratory motion management

(3回)

Neoplasms

新生物, 腫瘍

(3回)

RT(2回)

2020Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes.

recurrent refractory MM

(2回)

Hematology

血液学

(1回)

MM(2回)

NDMM(2回)

CR(1回)

2021[The Significance of CD319 and CD269 in the Detection of Immunophenotyping and Minimal Residual Disease in Multiple Myeloma Patients].

refractory to bortezomib and lenalidomide

(1回)

Allergy and Immunology

アレルギー・免疫

(1回)

2024Pomalidomide in patients with multiple myeloma: potential impact on the reconstitution of a functional T-cell immunity.

Relapsing-remitting multiple sclerosis

(病名) 再発寛解型多発性硬化症

(1回)

Medicine

医学, 医薬

(1回)

2020Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.

Relaxation Response and Mindfulness Meditation

(1回)

Neoplasms

新生物, 腫瘍

(1回)

KY(1回)

OCD(1回)

RCT(1回)

2005Patient perspectives: Kundalini yoga meditation techniques for psycho-oncology and as potential therapies for cancer.

recurrent and relapsed MM

(1回)

Biochemistry

生化学, 生物化学

(1回)

GEO(1回)

MM(1回)

NDMM(1回)

2021Proteomics-Based Approach Reveals the Involvement of SERPINB9 in Recurrent and Relapsed Multiple Myeloma.

recording respirable mass monitor

(1回)

Occupational Medicine

職業医学

(1回)

1978Laboratory evaluation of a recording respirable mass monitor.

range resolved mode mixing

(1回)

Ophthalmology

眼科学

(1回)

2015Range resolved mode mixing in a large volume for the mitigation of speckle and strategic target orientation requirements in active millimeter-wave imaging.